(Q37288758)

English

Ambrisentan

scientific article published on January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1 reference

Europe PubMed Central

Ambrisentan. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

author name string

Jamie D Croxtall

1

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Susan J Keam

2

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

68

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

2195-2204

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

https://scigraph.springernature.com/pub.10.2165/00003495-200868150-00008

0 references

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868150-00008

21 January 2018

Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelin receptor antagonists in pulmonary arterial hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ambrisentan for pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug treatment of pulmonary arterial hypertension: current and future agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of brain natriuretic peptide in primary pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelin receptor antagonists for pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sildenafil: a review of its use in pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical images: Drumstick-like fingers indicating psoriatic onycho-pachydermo periostitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nitric oxide and endothelin-1 in pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bosentan: a review of its use in pulmonary arterial hypertension and systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelin receptor antagonists in pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical therapy for pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical classification of pulmonary hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sitaxentan: in pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelin receptor antagonists for pulmonary arterial hypertension: rationale and place in therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ambrisentan therapy for pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18840007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200868150-00008

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37288758&oldid=2108832535"